Proteomics of cerebrospinal fluid (CSF) of acitretin treated patients
Version 1

Acitretin has been shown to increase ADAM10 expression. In a phase II clinical trial, Alzheimer's disease patients were treated with acitretin or placebo to increase ADAM10 levels to counteract amyloid beta production. Analysis of the cerebrospinal fluid of from 18 AD patients treated with the synthetic retinoid acitretin or placebo were analyzed by label-free quantitative LC-MS/MS analysis.

SEEK ID: http://lmmeisd-2.srv.mwn.de/data_files/62?version=1

help Creators and Submitter
Creators
Not specified
Submitter
Activity

Views: 145

Created: 8th Jul 2024 at 09:56

help Tags

This item has not yet been tagged.

help Attributions

None

Version History

Version 1 (earliest) Created 8th Jul 2024 at 09:56 by Rainer Malik

No revision comments

Powered by
(v.1.15.0)
Copyright © 2008 - 2024 The University of Manchester and HITS gGmbH